Camden On Gauley Medical Center Inc Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 415 Main St, Summersville, WV 26651 Phone: 304-872-1663 Fax: 304-872-8104 |
Fletcher And Fletcher Dentistry Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 402 Red Oak St., Summersville, WV 26651 Phone: 304-872-5600 |
Central West Virginia Sleep Solutions Pllc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 832 Broad St, Summersville, WV 26651 Phone: 304-872-3919 Fax: 304-872-4943 |
Katherine Wooton D.d.s., Inc Dentist Medicare: Not Enrolled in Medicare Practice Location: 702 Professional Park Dr Ste 100, Summersville, WV 26651 Phone: 304-872-7272 |
News Archive
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for ABILIFY® (aripiprazole) for the treatment of irritability associated with autistic disorder in pediatric patients ages 6 to 17 years, including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods.
Looking to gain further understanding about the impact of cancer on patients and families, The Cancer Institute of New Jersey (CINJ) is expanding its Quality and Outcomes in Cancer Care (QOCC) Research Program by welcoming nationally-recognized population science researcher Sharon Manne, PhD. Dr. Manne, who is the recipient of major grant awards from the National Institutes of Health (NIH) for her work in behavioral science, was most recently at the Fox Chase Cancer Center in Philadelphia. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.
Today a team of researchers from the Department of Veterinary Medicine and Animal Production of the Federico II University of Naples, in collaboration with the Sbarro Health Research Organization (SHRO), at Temple University in Philadelphia, and the Department of Biotechnology at the University of Siena, Itay, has discovered the effectiveness of a new extract, of natural origin.
Now, new research has found that children are still at a high risk of developing severe COVID-19. The study shows that one-third of children hospitalized due to COVID-19 were admitted to intensive care units (ICU), a rate similar to adults.
Nordic Naturals, the industry leader in omega-3 fish oil, introduces Kenai Wild™ Alaskan Salmon Oil to address the growing demand for salmon oil supplementation and to ensure that consumers have a choice that has been third-party tested for heavy metals including, arsenic, cadmium, lead, and mercury, and other contaminants such as PCBs.
› Verified 8 days ago